
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.02 | 0.02 | 0.00 |
Shares | 99.17 | 99.17 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Preferred | 0.22 | 0.22 | 0.00 |
Other | 0.55 | 0.55 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.36 | 19.18 |
Price to Book | 4.52 | 4.34 |
Price to Sales | 1.90 | 2.43 |
Price to Cash Flow | 16.79 | 16.74 |
Dividend Yield | 1.21 | 1.12 |
5 Years Earnings Growth | 12.37 | 12.19 |
Number of long holdings: 111
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.12 | 755.57 | +2.86% | |
UnitedHealth | US91324P1021 | 5.99 | 378.75 | -0.50% | |
AstraZeneca | GB0009895292 | 4.00 | 10,312.0 | +0.39% | |
Novo Nordisk B | DK0062498333 | 3.40 | 444.7 | +0.74% | |
J&J | US4781601046 | 3.31 | 154.14 | -0.05% | |
Abbott Labs | US0028241000 | 3.18 | 131.99 | -0.94% | |
Boston Scientific | US1011371077 | 3.09 | 102.87 | +0.01% | |
Sanofi | FR0000120578 | 2.89 | 90.90 | -0.26% | |
Amgen | US0311621009 | 2.77 | 274.76 | +3.35% | |
AbbVie | US00287Y1091 | 2.75 | 190.07 | +2.96% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 16.15B | -7.46 | 16.88 | 13.06 | ||
Janus Balanced I | 11.3B | -1.57 | 7.89 | 8.28 | ||
Janus Enterprise I | 8.61B | -5.25 | 8.08 | 11.03 | ||
Janus Henderson Balanced Portfolio | 8.19B | -1.60 | 7.67 | 8.01 | ||
Janus Enterprise N | 6.26B | -5.21 | 8.19 | 11.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review